February 2014

Epidarex Capital Leads New Investment in Edinburgh Molecular Imaging

Edinburgh, United Kingdom, February 7, 2014.  Epidarex Capital, a leading international early-stage life science venture capital fund, has announced a £4 million Series A investment, in Edinburgh Molecular Imaging (EMI). Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the round. EMI, an…